CPRX
Catalyst Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Catalyst Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Fund move
Fund move
No thesis.
Catalyst Pharmaceuticals, Inc.
31.50
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $602.2M | 17.75% | +2.05% | |
| 2 | State StreetState Streetindex-like | $239.7M | 7.06% | +11.13% | |
| 3 | American Century CompaniesAmerican Century Companies | $174.6M | 5.14% | +34.20% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $161.4M | 4.76% | +0.25% | |
| 5 | Dimensional Fund AdvisorsDimensional | $114.2M | 3.37% | +5.96% | |
| 6 | Glazer CapitalGlazer Capital | $113.2M | 3.34% | new | |
| 7 | JPMorgan ChaseJPMorgan Chase | $99.9M | 2.94% | +579.04% | |
| 8 | Geode Capital ManagementGeodeindex-like | $99.0M | 2.92% | +5.98% | |
| 9 | HBK Investments L PHBK Investments L P | $88.6M | 2.61% | new | |
| 10 | Morgan StanleyMorgan Stanley | $86.8M | 2.56% | +2.72% | |
| 11 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $76.3M | 2.25% | −1.88% | |
| 12 | Jupiter TopcoJupiter Topco | $71.6M | 2.11% | — | |
| 13 | Qube Research & TechnologiesQube Research & Technologies | $70.9M | 2.09% | +446.29% | |
| 14 | Renaissance TechnologiesRenaissance Technologies | $67.1M | 1.98% | −9.01% | |
| 15 | Boston PartnersBoston Partners | $52.2M | 1.54% | −3.08% | |
| 16 | Highland Capital Management Fund AdvisorsHighland | $50.4M | 1.48% | new | |
| 17 | UBS GroupUBS | $45.7M | 1.35% | +47.42% | |
| 18 | Northern TrustNorthern Trustindex-like | $41.8M | 1.23% | +7.49% | |
| 19 | Bank of AmericaBank of America | $41.2M | 1.21% | −56.81% | |
| 20 | Goldman Sachs GroupGoldman Sachs | $37.5M | 1.11% | +15.41% | |
| 21 | Charles Schwab Investment ManagementCharles Schwabindex-like | $36.4M | 1.07% | −18.91% | |
| 22 | Polar Asset Management PartnersPolar Asset Management Partners | $36.2M | 1.07% | new | |
| 23 | Millennium ManagementMillennium | $33.6M | 0.99% | +35.80% | |
| 24 | Water Island CapitalWater Island Capital | $29.3M | 0.86% | new | |
| 25 | Marshall WaceMarshall Wace | $28.7M | 0.84% | +351.75% |
393 managers report $3.4B of Catalyst Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 35 of them hold 80% of it; BlackRock is largest at 17.75%.
No implied move.
No implied move.
Expected move
No implied move.